Aarey Drugs & Pharmaceuticals shareholders and shareholding pattern
NSE: AAREYDRUGSBSE: 524412Pharmaceuticals & BiotechnologySmall Cap
Aarey Drugs & Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1994 on BSE, Aug 2021 on NSE
Last close ₹108.05up ₹1.47 (1.38%)BSE ₹108.40
Share price at the NSE close on 28 Oct 2026. Previous close ₹106.58.
28 Oct: open ₹102.11, high ₹109.70, low ₹102.11
52-week range of traded prices to 28 Oct 2026
₹50.31Low, 30 Mar 2026₹114.80High, 19 Oct 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹344 Cr2,366th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.33
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,40,50858.3% delivered
Aarey Drugs & Pharmaceuticals' shareholding pattern for Sep 2026, filed on 21 Oct 2026, with every filing from Dec 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Aarey Drugs & Pharmaceuticals, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters41.45%
- Foreign institutions4.27%
- Indian institutions1.44%
- Individuals and others52.83%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.94% | 53.40% | 53.40% | 58.04% | 58.05% | 49.86% | 49.86% | 49.85% | 50.44% | 50.44% | 50.44% | 50.77% | 51.00% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 48.05% | 48.06% | 50.03% | 50.03% | 50.03% | 50.04% | 50.04% | 50.04% | 50.04% | 45.28% | 45.28% | 45.44% | 44.80% | 44.80% | 44.80% | 44.80% | 39.06% | 37.71% | 37.71% | 41.45% | |
| Indian promoters | 54.94% | 53.40% | 53.40% | 58.04% | 58.05% | 49.86% | 49.86% | 49.85% | 50.44% | 50.44% | 50.44% | 50.77% | 51.00% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 48.05% | 48.06% | 50.03% | 50.03% | 50.03% | 50.04% | 50.04% | 50.04% | 50.04% | 45.28% | 45.28% | 45.44% | 44.80% | 44.80% | 44.80% | 44.80% | 39.06% | 37.71% | 37.71% | 41.45% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 45.06% | 46.60% | 46.60% | 41.96% | 41.95% | 50.14% | 50.14% | 50.15% | 49.56% | 49.56% | 49.56% | 49.23% | 49.00% | 50.62% | 50.62% | 50.62% | 50.62% | 50.62% | 50.62% | 50.62% | 51.95% | 51.94% | 49.97% | 49.97% | 49.97% | 49.96% | 49.96% | 49.96% | 49.96% | 54.72% | 54.72% | 54.56% | 55.20% | 55.20% | 55.20% | 55.20% | 60.94% | 62.29% | 62.29% | 58.55% |
| Shares in issue | 1,75,79,684 | 1,80,84,684 | 1,80,84,684 | 2,00,84,684 | 2,00,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,80,54,303 | 2,80,54,303 | 2,79,54,303 | 2,83,54,303 | 2,83,54,303 | 2,83,54,303 | 2,83,54,303 | 2,83,54,303 | 2,83,54,303 | 2,83,54,303 | 3,18,74,303 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 41,25,000 | 33,60,000 | 12,70,000 | – | – | 58,65,000 | 53,60,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 8,00,000 | – | 87,60,834 | 94,60,834 | 94,60,834 | 1,07,60,834 | 1,08,49,946 | 20,00,000 | 98,63,584 | 98,63,584 | 98,63,584 | 1,27,02,443 | 1,31,67,860 | 37,85,036 | 11,18,695 | 36,88,314 | 1,61,41,257 | 1,31,02,943 | 1,31,02,943 | – | – | – | – |
| Promoters' shares locked in | 33,60,000 | 33,60,000 | 0 | – | – | 53,60,000 | 53,60,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 8,00,000 | – | 87,10,834 | 93,60,834 | 93,60,834 | 93,60,834 | 93,60,834 | 6,50,000 | 98,63,584 | 98,63,584 | 98,63,584 | 1,27,02,443 | 1,27,02,443 | 6,50,000 | 6,50,000 | 6,50,000 | 1,27,02,443 | 1,27,02,443 | 1,27,02,443 | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Aarey Drugs & Pharmaceuticals promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Bina Rajesh Ghatalia, 14.13%. The filing names 3 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Bina Rajesh GhataliaIndividuals and Hindu undivided families | 14.13% | 45,03,584 |
| Mihir Rajesh GhataliaIndividuals and Hindu undivided families | 9.98% | 31,80,888 |
| Nimit ImpexIndian companies, trusts and others | 6.31% | 20,10,000 |
| Nimit Rajesh GhataliaIndividuals and Hindu undivided families | 5.18% | 16,50,000 |
| Mira Mihir GhataliaIndividuals and Hindu undivided families | 2.95% | 9,40,000 |
| Ekta Nimit GhataliaIndividuals and Hindu undivided families | 1.57% | 5,00,000 |
| MIHIR RAJESH GHATALIA HUFIndividuals and Hindu undivided families | 0.77% | 2,45,000 |
| Rajesh Pranlal GhataliaIndividuals and Hindu undivided families | 0.57% | 1,82,971 |
No promoter shares are reported as pledged.
Largest public holders of Aarey Drugs & Pharmaceuticals, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elysian Wealth FundForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.65% | 3.12% | 3.12% | 2.78% |
| Krishnamurthy C GResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.73% | 1.73% | 1.73% | 1.76% | 1.76% | 1.76% | 1.57% |
| Suvi Rubber Pvt LtdCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.12% | 2.12% | 1.65% | 1.47% |
| Shree Salasar Properties and Finance Private LimitedNon-bank lenders registered with RBI | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.62% | 1.62% | 1.44% |
| Chetan Kirtibhai MehtaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.18% | – | 1.18% | 1.18% | 1.18% | 1.18% | 1.18% | 1.60% | 1.60% | 1.07% | 1.59% | 1.59% | 1.59% | 1.59% | 1.59% | 1.41% | 1.41% | 1.25% |
| Richa BothraResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.26% | 1.36% | 1.21% |
| Resonance Opportunities FundForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.05% | – | 1.05% | – |
| Vijay Kumar Babulal ShahResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.06% | 1.06% | 1.06% | 1.04% | 1.04% | 1.04% | 1.04% | – |
| Kls Commodities Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.02% | – |
| Mvm Commodities Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.11% | – | – |
| Resonance Opportunity fundForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.05% | – | – |
| Nishith Atulbhai ShahResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.42% | – | – | – |
| Archana Pramod WaniResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.41% | 1.41% | 1.41% | 1.41% | – | – | – |
| India Opportunities Growth Fund Ltd - Pinewood StrategyForeign portfolio investors, category I | – | – | – | – | – | 4.81% | 4.90% | 4.90% | 4.90% | 4.90% | 4.90% | 4.90% | 4.90% | 4.90% | 3.10% | 3.21% | 3.21% | 3.21% | 3.21% | – | – | 3.92% | 3.92% | 3.92% | 3.92% | 3.92% | 3.92% | 3.92% | 3.83% | 3.40% | 3.40% | 2.67% | 2.34% | – | 1.73% | – | – | – | – | – |
| INDIA OPPORTUNITIES GROWTH FUND nLTD - PINEWOODForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.34% | – | – | – | – | – | – |
| Black Hawk Properties Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.35% | 1.35% | – | – | 1.34% | – | – | – | – | – | – |
| Zil Penil DoshiResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.48% | – | 1.48% | 1.48% | 1.48% | 1.48% | 1.48% | 1.34% | 1.34% | 1.34% | 1.32% | 1.32% | – | – | – | – | – | – |
| C G KrishnamurthyResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.83% | – | 1.83% | 1.83% | 1.83% | 1.93% | 1.93% | 1.75% | 1.75% | 1.75% | 1.73% | – | – | – | – | – | – | – |
| Vijaykumar B ShahResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.07% | 1.07% | – | – | – | – | – | – | – | – | – |
| Dinesh Kumar JainResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.14% | – | 1.38% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Narendrakumar Bhagwandas GuptaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.07% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Aidos India Fund LtdInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.81% | 3.81% | 3.81% | 3.70% | 3.70% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Lts Investment Fund LtdInstitutions Foreign Portfolio Investor | – | – | – | – | – | 4.70% | 4.13% | 4.13% | 4.13% | 4.13% | 4.13% | 4.13% | 4.13% | 4.13% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Elara India Opportunities Fund LimitedInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | 1.08% | 1.08% | 1.08% | 1.51% | 1.51% | 1.51% | 1.51% | 1.51% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Nomura Singapore LimitedInstitutions Foreign Portfolio Investor | – | – | – | – | – | 4.70% | 4.28% | 4.28% | 4.28% | 4.28% | 4.28% | 4.28% | 3.42% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Urmila Rameshchandra MehtaResident individuals, over ₹2 lakh at face value | 1.84% | 2.38% | 2.74% | 1.74% | 1.49% | – | – | – | 1.73% | 1.91% | 2.44% | – | 2.90% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Ankur ModiResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | 1.15% | 1.53% | 1.60% | 1.60% | – | 1.89% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Arcadia Share &Stock Brokers Pvt LtdOther non-institutions | 2.05% | 2.02% | 1.34% | 1.01% | – | 1.02% | 1.61% | 1.39% | 1.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Shriram Insight Share Brokers LtdOther non-institutions | – | – | – | – | – | 1.91% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Maxgrow Fintrade Private LimitedOther non-institutions | – | – | 1.04% | 1.41% | 1.19% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Gedalia Multitrading Private LimitedOther non-institutions | – | – | – | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| B N MittalOther non-institutions | – | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Aug 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Foreign institutions: Elysian Wealth Fund 2.78%, −0.09 pts
- Indian institutions: Shree Salasar Properties and Finance Private Limited 1.44%, −0.05 pts
- Individuals and others: Chetan Kirtibhai Mehta 1.25%, −0.05 pts; Krishnamurthy C G 1.57%, −0.05 pts; Suvi Rubber Pvt Ltd 1.47%, −0.05 pts; 1 more moved